Neurofibroma (patient information): Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 19: Line 19:
{{CMG}};  Jinhui Wu, MD
{{CMG}};  Jinhui Wu, MD


==Overview of neurofibroma==
==Overview==
Neurofibroma is genetic disorders of the nervous system that result in the growth of noncancerous tumors along nerves. Studies suggested that the cause of neurofibroma is related to gene mutations. There are two main forms of neurofibroma: peripheral neurofibromatosis and central neurofibromatosis.  
Neurofibroma is genetic disorders of the nervous system that result in the growth of noncancerous tumors along nerves. Studies suggested that the cause of neurofibroma is related to gene mutations. There are two main forms of neurofibroma: peripheral neurofibromatosis and central neurofibromatosis.  



Revision as of 01:18, 29 July 2011

For the WikiDoc page for this topic, click here

Neurofibroma (patient information)
ICD-O: 9540-9550
DiseasesDB 23371
MeSH D009455

WikiDoc Resources for Neurofibroma (patient information)

Articles

Most recent articles on Neurofibroma (patient information)

Most cited articles on Neurofibroma (patient information)

Review articles on Neurofibroma (patient information)

Articles on Neurofibroma (patient information) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Neurofibroma (patient information)

Images of Neurofibroma (patient information)

Photos of Neurofibroma (patient information)

Podcasts & MP3s on Neurofibroma (patient information)

Videos on Neurofibroma (patient information)

Evidence Based Medicine

Cochrane Collaboration on Neurofibroma (patient information)

Bandolier on Neurofibroma (patient information)

TRIP on Neurofibroma (patient information)

Clinical Trials

Ongoing Trials on Neurofibroma (patient information) at Clinical Trials.gov

Trial results on Neurofibroma (patient information)

Clinical Trials on Neurofibroma (patient information) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Neurofibroma (patient information)

NICE Guidance on Neurofibroma (patient information)

NHS PRODIGY Guidance

FDA on Neurofibroma (patient information)

CDC on Neurofibroma (patient information)

Books

Books on Neurofibroma (patient information)

News

Neurofibroma (patient information) in the news

Be alerted to news on Neurofibroma (patient information)

News trends on Neurofibroma (patient information)

Commentary

Blogs on Neurofibroma (patient information)

Definitions

Definitions of Neurofibroma (patient information)

Patient Resources / Community

Patient resources on Neurofibroma (patient information)

Discussion groups on Neurofibroma (patient information)

Patient Handouts on Neurofibroma (patient information)

Directions to Hospitals Treating Neurofibroma (patient information)

Risk calculators and risk factors for Neurofibroma (patient information)

Healthcare Provider Resources

Symptoms of Neurofibroma (patient information)

Causes & Risk Factors for Neurofibroma (patient information)

Diagnostic studies for Neurofibroma (patient information)

Treatment of Neurofibroma (patient information)

Continuing Medical Education (CME)

CME Programs on Neurofibroma (patient information)

International

Neurofibroma (patient information) en Espanol

Neurofibroma (patient information) en Francais

Business

Neurofibroma (patient information) in the Marketplace

Patents on Neurofibroma (patient information)

Experimental / Informatics

List of terms related to Neurofibroma (patient information)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Jinhui Wu, MD

Overview

Neurofibroma is genetic disorders of the nervous system that result in the growth of noncancerous tumors along nerves. Studies suggested that the cause of neurofibroma is related to gene mutations. There are two main forms of neurofibroma: peripheral neurofibromatosis and central neurofibromatosis.

Peripheral neurofibromatosis is common. Usual signs of peripheral neurofibromatosis includes more tan spots on the skin, freckles, lumps on the skin and a variety of bone defects, such as bowing of the legs below the knee. Biopsy is the best way for diagnosis. In some cases, genetic testing of a blood sample is needed to confirm the diagnosis. For treatment, surgery can curative. However, they often grow back.

Central neurofibromatosis is rare. Severity of symptoms varies greatly. They depend on the nerve infiltrated. Acoustic nerve is the most commonly affected. Nervous system examination, hearing tests, computed tomography (CT) and magnetic resonance imaging (MRI) may help the diagnosis. In some cases, genetic testing is done to help confirm the diagnosis. Treatments of central neurofibromatosis include surgery, radiation therapy, chemotherapy, or a combination of them.

See also

Where to find medical care for neurofibroma?

Directions to Hospitals Treating neurofibroma

Sources

http://www.marchofdimes.com/pnhec/4439_1217.asp

Template:WH Template:WS